JP Morgan Chase’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $458K | Sell |
388,103
-38,676
| -9% | -$63.9K | ﹤0.01% | 5086 |
|
|
2025
Q4 | $943K | Sell |
426,779
-70,323
| -14% | -$132K | ﹤0.01% | 4653 |
|
|
2025
Q3 | $805K | Sell |
497,102
-94,739
| -16% | -$198K | ﹤0.01% | 4742 |
|
|
2025
Q2 | $1.53M | Sell |
591,841
-62,542
| -10% | -$247K | ﹤0.01% | 4108 |
|
|
2025
Q1 | $4.4M | Sell |
654,383
-114,047
| -15% | -$807K | ﹤0.01% | 3266 |
|
|
2024
Q4 | $5.22M | Sell |
768,430
-287,092
| -27% | -$1.89M | ﹤0.01% | 3300 |
|
|
2024
Q3 | $8.75M | Buy |
1,055,522
+25,002
| +2% | +$181K | ﹤0.01% | 2721 |
|
|
2024
Q2 | $6.53M | Buy |
1,030,520
+765,945
| +290% | +$5.89M | ﹤0.01% | 2829 |
|
|
2024
Q1 | $2.45M | Buy |
264,575
+212,312
| +406% | +$2.49M | ﹤0.01% | 3687 |
|
|
2023
Q4 | $666K | Buy |
52,263
+26,831
| +106% | +$279K | ﹤0.01% | 4607 |
|
|
2023
Q3 | $263K | Sell |
25,432
-3,988
| -14% | -$46.2K | ﹤0.01% | 4891 |
|
|
2023
Q2 | $386K | Sell |
29,420
-118,798
| -80% | -$1.45M | ﹤0.01% | 4655 |
|
|
2023
Q1 | $1.66M | Buy |
148,218
+90,404
| +156% | +$893K | ﹤0.01% | 3670 |
|
|
2022
Q4 | $487K | Buy |
57,814
+25,051
| +76% | +$238K | ﹤0.01% | 4542 |
|
|
2022
Q3 | $545K | Buy |
32,763
+1,026
| +3% | +$18.9K | ﹤0.01% | 4400 |
|
|
2022
Q2 | $467K | Buy |
31,737
+4,927
| +18% | +$101K | ﹤0.01% | 4606 |
|
|
2022
Q1 | $665K | Sell |
26,810
-24,794
| -48% | -$640K | ﹤0.01% | 4520 |
|
|
2021
Q4 | $1.66M | Sell |
51,604
-107,589
| -68% | -$3.93M | ﹤0.01% | 3998 |
|
|
2021
Q3 | $5.73M | Buy |
159,193
+146,960
| +1,201% | +$5.78M | ﹤0.01% | 2921 |
|
|
2021
Q2 | $540K | Sell |
12,233
-102,318
| -89% | -$4.46M | ﹤0.01% | 4643 |
|
|
2021
Q1 | $5.24M | Buy |
114,551
+86,886
| +314% | +$4.98M | ﹤0.01% | 2935 |
|
|
2020
Q4 | $1.91M | Buy |
+27,665
| New | +$1.35M | ﹤0.01% | 3503 |
|
Other funds holding LUNG
SCM
ECM
VCM
